Galapagos NV: business update: http://t.co/6w1jppWE
posted 5 days ago
FlandersBio informs you about important regional and national life sciences news. Send us your news. If your news is of interest to the life sciences community, we will post it on our website.
Patrik De Haes has been appointed as the new chairman of the Board of Directors of FlandersBio. He succeeds Johan Cardoen who stands down after five years in the post. Patrik De Haes, who is the CEO of ThromboGenics, has been a director of FlandersBio for the last two years. read more
QUINVITA, the Industrial Crop Technology Company today announced the closure of its capital round, raising EUR 1.5 million from a group of investors including Think2Act Arkiv, Group Vanden Avenne Izegem and a number of private investors. read more
Earlier this year Rudy Dekeyser announced his departure from VIB, to accept a new challenge in the venture capital world. Since the start of VIB in July 1995, VIB has been led by the tandem Jo Bury and Rudy Dekeyser. From June 1st onwards Johan Cardoen will succeed Rudy Dekeyser as managing director and director tech transfer of VIB. read more
Have you ever wondered why stems grow upwards and roots downwards? Why plants always seem to turn towards the light and climbing plants run up the trellis rather than down? read more
In accordance with Article 15 §1 of the Act of 2 May 2007 on the disclosure of major shareholdings, Devgen nv today announces the issuance of 11,479 common shares by the Company as the result of the exercise of warrants. As a result of this transaction, Devgen now has 24,277,879 shares outstanding. read more
